Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
09/07/2001 | CA2401660A1 Lipid metabolism enzymes |
09/07/2001 | CA2401652A1 High potency recombinant antibodies and method for producing them |
09/07/2001 | CA2401633A1 Modulation of pleiotrophin signaling by receptor-type protein tyrosine phosphatase .beta./.zeta. |
09/07/2001 | CA2401627A1 Cellular telephone interactive wagering system |
09/07/2001 | CA2401621A1 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis |
09/07/2001 | CA2401607A1 Methods for selectively modulating survivin apoptosis pathways |
09/07/2001 | CA2401603A1 Trisomy 21 cytotrophoblast cultures, and uses thereof for obtaining trisomy 21 markers |
09/07/2001 | CA2401580A1 Affinity matrix bearing tumor-associated antigens |
09/07/2001 | CA2401453A1 G-proteins coupled receptor related polypeptides |
09/07/2001 | CA2401175A1 Chordin-like-2 molecules and uses thereof |
09/07/2001 | CA2401173A1 G12l, a gene associated with the thermal response |
09/07/2001 | CA2400766A1 Aspartate carbamyltransferase as herbicidal target |
09/07/2001 | CA2400679A1 Human schizophrenia gene |
09/07/2001 | CA2400595A1 Human schizophrenia gene |
09/07/2001 | CA2400591A1 Method and apparatus for handling diverse body fluids |
09/07/2001 | CA2400376A1 Methods for detection and treatment of neural cancers |
09/07/2001 | CA2400126A1 Process for estimating random error in chemical and biological assays when random error differs across assays |
09/07/2001 | CA2399889A1 Method for identifying an agent for treatment of niddm diabetes by interaction with compound u0126 |
09/07/2001 | CA2399847A1 Antibodies binding a gamma carboxyglutamic acid displaying epitope |
09/07/2001 | CA2399140A1 Method for continuous determination of the properties of a flow of wood fibres for fabrication of fibreboard |
09/07/2001 | CA2397502A1 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies |
09/06/2001 | US20010020272 Method and system for caching virus-free file certificates |
09/06/2001 | US20010020098 For labeling target molecules |
09/06/2001 | US20010020087 Imidazolinone haptens and antigens and enzyme conjugates prepared therefrom |
09/06/2001 | US20010020012 Administering ligands for growth horomne receptors |
09/06/2001 | US20010020010 Polypeptide |
09/06/2001 | US20010019846 Assay and reagent kit for evaluation of multi-drug resistance in cells |
09/06/2001 | US20010019844 Detection of base contaminants in gas samples |
09/06/2001 | US20010019842 Separation low specific gravity fluid from high specific gravity fluid by centrifugal force |
09/06/2001 | US20010019835 Gene amplifying method |
09/06/2001 | US20010019832 Detection of diabtes |
09/06/2001 | US20010019831 Minimum procedure system for the determination of analytes |
09/06/2001 | US20010019830 Signal transfer mechanism of tumor necrosis factor |
09/06/2001 | US20010019829 Mass spectrometric immunoassay |
09/06/2001 | US20010019827 Bundling of target strands; immobilization |
09/06/2001 | US20010019824 Sample preparation method and a sample preparation apparatus for DNA analysis |
09/06/2001 | US20010019821 Determination concentration of antibody in liquid sampling |
09/06/2001 | US20010019820 Labeling with radioactive naterials |
09/06/2001 | US20010019405 Diagnostic device and method |
09/06/2001 | US20010019106 Process and devices for characterising ground water measurement points by distinguishing ground water from subterranean water accumulation |
09/06/2001 | US20010018844 Method and apparatus for calibrating an air monitor using a flexible element flow matching valve |
09/06/2001 | DE19824609C2 Verfahren zur Online-Überwachung der Einhaltung vorgegebener Grenzwerte und Parameter in Fluids und Einrichtung zur Durchführung des Verfahrens A method for on-line monitoring of compliance with specified limits and parameters in fluid and means for carrying out the method |
09/06/2001 | DE10107360A1 Novel metalloprotease containing a thrombospondin domain (MPTS protein) is useful to treat aggrecan associated disease including rheumatoid arthritis and osteoarthritis |
09/06/2001 | DE10010587A1 System zur Bestimmung von Analytkonzentrationen in Körperflüssigkeiten System for the determination of analyte concentrations in body fluids |
09/06/2001 | DE10010291A1 Calorimetry method for flow of gaseous fuel introduces heat at controlled rate from burner to thermal transfer element with heat sink, and measures thermal state parameter |
09/06/2001 | DE10010282A1 Verfahren zur Detektion von Cytosin-Methylierung in DNA Proben Process for detection of cytosine methylation in DNA samples |
09/06/2001 | DE10010281A1 Ligase/Polymerase-Verfahren zur Detektion von Cytosin-Methylierung in DNA Proben Ligase / polymerase method for the detection of cytosine methylation in DNA samples |
09/06/2001 | DE10009420A1 Determining chemotaxis activity of leukocytes, useful for diagnosing e.g. immune defects comprises measuring expression of cell-adhesion molecules |
09/06/2001 | DE10009341A1 Verfahren zur antigen-spezifischen Stimulation von T-Lymphozyten A method for antigen-specific stimulation of T lymphocytes |
09/06/2001 | DE10009143A1 Nachweis von Humanen Papillomviren Detection of human papillomavirus |
09/06/2001 | DE10006889A1 Verwendung von Inhibitoren von Caspase-3 oder der Caspase-aktivierten Desoxyribonuclease (CAD) zur Behandlung von Herzerkrankungen Use of inhibitors of caspase-3 or caspase-activated deoxyribonuclease (CAD) for the treatment of heart disease |
09/06/2001 | DE10006846A1 Process for measuring the photometric chemical oxygen requirement of liquid samples comprises using several cuvettes in a holder located or inserted in a dosing device |
09/05/2001 | EP1130402A2 Ready-to-use long term stable ristocetin co-factor test reagent |
09/05/2001 | EP1130401A2 Assays for measurement of type II collagen fragments in urine |
09/05/2001 | EP1130400A1 Assay for ABCA1 |
09/05/2001 | EP1130399A2 Method and product for the sequence determination of peptides using a mass spectrometer |
09/05/2001 | EP1130398A2 Analytical elements |
09/05/2001 | EP1130397A2 Equipment for determination of an analyte from a sample |
09/05/2001 | EP1130396A1 Measuring method and measuring reagent of C-reactive protein |
09/05/2001 | EP1130395A2 Method and apparatus for production visual results using colorimetric strips |
09/05/2001 | EP1130394A1 In vitro models of CNS function and dysfunction |
09/05/2001 | EP1130393A2 Gas sensor and gas sensor system |
09/05/2001 | EP1130392A1 Method for selecting starches |
09/05/2001 | EP1130388A1 Improved sensor membranes |
09/05/2001 | EP1130387A1 Linker lipid for sensor membranes |
09/05/2001 | EP1130386A1 Improved sensor membranes |
09/05/2001 | EP1130383A1 System for analysing the components of fluid samples |
09/05/2001 | EP1130381A1 Transmission meter, a method of measuring transmittance and a disinfection apparatus |
09/05/2001 | EP1130378A1 Method and device for determining fluidity of fluid in container |
09/05/2001 | EP1130377A1 Apparatus for automatic identification and processing of objects |
09/05/2001 | EP1130123A2 Diagnostic method |
09/05/2001 | EP1130122A2 Methods for the diagnosis of polymorphisms in the human EP1-R gene |
09/05/2001 | EP1130111A2 Diagnostics based on tetrazolium compounds |
09/05/2001 | EP1130110A2 Assay for evaluating inhibition of cyclooxygenase-2 |
09/05/2001 | EP1130098A2 Mammalian osteoregulins |
09/05/2001 | EP1130087A2 A method to identify compounds that alter the apoptotic process |
09/05/2001 | EP1130086A1 Genetically engineered keratinocytes and toxicity assay using said keratinocytes |
09/05/2001 | EP1130030A1 Human erythroid differentiation related factor |
09/05/2001 | EP1130009A1 Generation and screening of a dynamic combinatorial library |
09/05/2001 | EP1129779A2 Container for centrifugation |
09/05/2001 | EP1129778A2 System for determining the concentration of an analyte in body fluids |
09/05/2001 | EP1129707A2 Methods for identifying and treating resistant tumors |
09/05/2001 | EP1129356A2 A method for the determination of homocysteine |
09/05/2001 | EP1129355A1 Use of radioligands to screen inhibitors of amyloid-beta peptide production |
09/05/2001 | EP1129354A1 A method for determining a mimotope sequence |
09/05/2001 | EP1129353A1 Minimally invasive methods for measuring analytes in vivo |
09/05/2001 | EP1129352A1 Assay for phosphatase-targeting toxins |
09/05/2001 | EP1129351A2 COMPOSITIONS AND METHODS RELATING TO THE PEROXISOMAL PROLIFERATOR ACTIVATED RECEPTOR-$g(a) MEDIATED PATHWAY |
09/05/2001 | EP1129350A1 Methods for identifying modulators of bs69 activity |
09/05/2001 | EP1129347A2 Apparatus and methods relating to humidified air and to olfactory monitoring |
09/05/2001 | EP1129344A1 Methods and formulations for the separation of biological macromolecules |
09/05/2001 | EP1129336A1 Device and method for rapid evaluation of bonding reactions in structured interferometric microtitre plates |
09/05/2001 | EP1129334A1 Method for the quantitative determination of polyaspartic acid |
09/05/2001 | EP1129332A1 In-stack direct particulate mass measurement apparatus and method with pressure/flow compensation |
09/05/2001 | EP1129217A2 Compositions and methods of disease diagnosis and therapy |
09/05/2001 | EP1129216A2 Methods, software and apparati for identifying genomic regions harboring a gene associated with a detectable trait |
09/05/2001 | EP1129213A1 Bacillus strain and assay methods |
09/05/2001 | EP1129212A1 Screening process for antibacterial agents |
09/05/2001 | EP1129211A1 Electrode strips for testing small volumes |
09/05/2001 | EP1129202A2 Chlamydia antigenes and corresponding dna fragments and uses thereof |